T1	intervention 63 89	photobiomodulation therapy
T2	condition 111 137	acute radiation dermatitis
T3	total-participants 413 416	120
T4	eligibility 417 508	breast cancer patients who underwent an identical radiotherapy (RT) regimen post-lumpectomy
T5	control 662 669	placebo
T6	outcome 926 957	incidence of moist desquamation
T7	cv-bin-percent 1039 1041	30
T8	iv-bin-percent 1046 1048	7%
T9	outcome 1179 1211	transepidermal water loss (TEWL)
T10	outcome 1213 1221	erythema
T11	outcome 1227 1241	melanin values
T12	outcome 1390 1408	moist desquamation
